ARMP
Armata Pharmaceuticals Inc (ARMP)
Healthcare • NYSE MKT • $7.15+2.00%
- Symbol
- ARMP
- Exchange
- NYSE MKT
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $7.15
- Daily Change
- +2.00%
- Market Cap
- $259.91M
- Trailing P/E
- N/A
- Forward P/E
- -4.51
- 52W High
- $16.34
- 52W Low
- $1.81
- Analyst Target
- $17.50
- Dividend Yield
- N/A
- Beta
- N/A
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Company websiteResearch ARMP on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.